Stuttgart - Thieme Publishing Group today announced the launch of Pharmaceutical Substances Version 3.3. Compiled by Prof. A. Kleemann, Prof. J. Engel, Prof. B. Kutscher and Dr. D. Reichert, renowned leaders in the field, this comprehensive reference guide to every significant pharmaceutical compound contains syntheses, patents and applications of all FDA approved active pharmaceutical ingredients (APIs) and is available through Thieme-connect (www.thieme-connect.com). "With this new release we have added 20 recently approved APIs, including the LH-RH antagonist Degarelix, the antiarrhythmic Dronedarone, the antiepileptic Lacosamide, and the GLP-1 analogue Liraglutide, which all represent the first members of new drug substance classes. The total number of APIs covered in Pharmaceutical Substances has now reached 2500. Along with these additions, the entries for Azelastine, Dexrazoxane and Teriparatide have been updated,” says Prof. Dr. Axel Kleemann, one of the authors of Pharmaceutical Substances. Developed in association with InfoChem and FIZ Chemie, the online version of the information resource is a web-based, easy-to-navigate portal that utilizes standard browser technology. The user- friendly interface enables users to rapidly locate data and graphically search structures. Pharmaceutical Substances is an invaluable reference for everyone involved in the design, discovery, development, and evaluation of drugs. About InfoChem
InfoChem GmbH (www.infochem.de), based in Munich, Germany, is a market leader in structure and reaction handling and retrieval. Founded in 1989, InfoChem focuses on the production and marketing of new chemical information products, including structural and reaction databases, and the development of software tools required for these applications. The main software tools provided are the InfoChem Fast Search Engine (ICFSE), the InfoChem Chemistry Cartridge for Oracle (ICCARTRIDGE), and the widely used InfoChem reaction classification algorithm, CLASSIFY. Springer (Heidelberg) has held a majority interest in InfoChem since 1991. About Thieme
Thieme Publishing Group is a privately held STM publishing house employing more than 950 people and maintaining offices in seven cities, including New York, Delhi, Stuttgart and three other locations in Germany. Founded in 1886, the Thieme name has become synonymous with high quality and excellence in medical and scientific publishing. Today, Thieme is the market leading publisher of neurosurgical content and holds strong market positions in orthopedics, radiology, anatomy and chemistry, among other specialties. Thieme publishes 137 peer-reviewed journals and over 500 new books annually. The company also has a rapidly growing array of web-based products in medicine and science. Popular online products include Thieme eJournals and the Thieme ElectronicBook Library, which are accessible via www.thieme-connect.com, Thieme's platform for electronic products. Contact
e-Statement Agreement and Disclosure This Agreement governs the receipt of your periodic account statements for those accounts which you designate ("Designated Accounts") through Online Banking. In addition, you may receive most disclosures and notices (“Disclosures”) on your Designated Accounts through the same web-based electronic service instead of by U.S. mail. These Disclosure
Cives Centro de Informação em Saúde para Viajantes Dengue: perguntas & respostas Fernando S. V. Martins & Terezinha Marta P.P. Castiñeiras 1. O que é dengue? • É uma virose transmitida por um tipo de mosquito ( Aëdes aegypti ) que pica apenas durante o dia, ao contrário do mosquito comum ( Culex ), que pica de noite. A infecção pode ser causada por qualque